Insulin glargine and lixisenatide and Sargramostim Intravenous
Determining the interaction of Insulin glargine and lixisenatide and Sargramostim Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: sargramostim
Brand name: Leukine
Synonyms: Sargramostim
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Sargramostim Powder for Injection
- Insulin glargine and lixisenatide-Sargramostim Solution for Injection
- Insulin glargine and lixisenatide-Sarilumab
- Insulin glargine and lixisenatide-Sarilumab Prefilled Pens
- Insulin glargine and lixisenatide-Sarilumab Prefilled Syringes
- Insulin glargine and lixisenatide-Sarilumab Subcutaneous
- Sargramostim Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Sargramostim Intravenous-Insulin glargine, recombinant Subcutaneous
- Sargramostim Intravenous-Insulin glulisine
- Sargramostim Intravenous-Insulin Glulisine (Cartridges and Pens)
- Sargramostim Intravenous-Insulin Glulisine (Vials)
- Sargramostim Intravenous-Insulin glulisine Subcutaneous